Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
ORIC Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ORIC
Nasdaq
8731
http://oricpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for ORIC Pharmaceuticals Inc
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC
- Apr 15th, 2024 8:15 pm
ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Apr 8th, 2024 12:00 pm
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
- Apr 5th, 2024 8:30 pm
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
- Apr 4th, 2024 8:30 pm
How Much Upside is Left in Oric Pharmaceuticals (ORIC)? Wall Street Analysts Think 39.3%
- Mar 26th, 2024 1:55 pm
ORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial Results
- Mar 13th, 2024 1:01 am
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates
- Mar 11th, 2024 8:05 pm
ORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 Shares
- Mar 8th, 2024 10:01 pm
ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
- Mar 6th, 2024 9:30 pm
ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
- Mar 5th, 2024 9:30 pm
ORIC Pharmaceuticals to Participate in the Citi 2024 Virtual Oncology Leadership Summit
- Feb 14th, 2024 9:30 pm
ORIC Pharmaceuticals CEO Jacob Chacko Sells 40,000 Shares
- Feb 9th, 2024 7:23 am
Recent Price Trend in Oric Pharmaceuticals, Inc. (ORIC) is Your Friend, Here's Why
- Feb 8th, 2024 1:50 pm
Oric Pharmaceuticals, Inc. (ORIC) Is a Great Choice for 'Trend' Investors, Here's Why
- Jan 23rd, 2024 1:50 pm
ORIC Pharmaceuticals Announces $125 Million Private Placement Financing
- Jan 22nd, 2024 1:30 pm
Final Boarding Call: 3 Stocks Set for a Sky-High Surge
- Jan 9th, 2024 5:31 pm
ORIC Pharmaceuticals Provides Initial Phase 1b Data for ORIC-944, Operational Highlights for 2023, and Anticipated Upcoming Milestones
- Jan 8th, 2024 1:30 pm
ORIC Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Jan 2nd, 2024 9:30 pm
Initial Phase 1 Dose Escalation Data for ORIC-533 in Relapsed/Refractory Multiple Myeloma Demonstrates Clinical Activity and Strong Safety Profile Supporting Potential for Combination Development
- Dec 11th, 2023 5:00 pm
3 Stocks at the Forefront of Personalized Medicine Trend
- Dec 5th, 2023 2:11 pm
Scroll